GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
Licensing Immunotherapy Drug
FDA’s Advisory Committee Recommends Palforzia’s approval for Peanut Allergy Treatment
2019-09-27
Trials & Approvals Personalized Medicine
Rozlytrek Becomes the Third Tumor-Agnostic Medicine to be Approved by the USFDA
2019-08-21
Trials & Approvals ATM
Lynparza Meets Primary Endpoint in Phase III PROfound Trial
2019-08-16
Manufacturing ELARIS UF-I
AbbVie Files New Drug Application for its GnRH Antagonist
2019-08-13
Deals Gene Therapy
Sangamo’s Shares Goes up after the Announcement of Investigational Hemophilia A Gene Therapy Results
2019-07-19
Trials & Approvals Rare Disease
FDA Okays Expensive Gene Therapy for Infantile-Onset Spinal Muscular Atrophy
2019-05-29
Trials & Approvals CDK4/6
Kisqali Fulvestrant Combo Rejected by NICE for Breast Cancer Treatment in the UK
2019-05-02
Trials & Approvals EGFR
Erdafitinib Approval,a Bright Spot Amid the Troughs in Bladder Cancer Trials
2019-04-23
Trials & Approvals EGFR
Vizimpro bags EU approval for NSCLC treatment
2019-04-16
Trials & Approvals Anxiety
FDA Approves New Drug for Specific Treatment of Postpartum Depression
2019-03-21
Trials & Approvals Breast Cancer
Tecentriq/Arbaxane Combo Becomes the First FDA Approved Immunotherapy Regimen for Breast Cancer Treatment
2019-03-14
Trials & Approvals Breast Cancer
Herceptin Hylecta bags FDA approval for HER2-Positive Breast Cancer Treatment
2019-03-04
Trials & Approvals Ovarian Cancer
First PARP inhibitor approved for 1L maintenance therapy of BRCAm advanced ovarian cancer
2018-12-28
Trials & Approvals Antibody
Tecentriq bags yet another FDA approval, this time as a combo therapy for NSCLC
2018-12-24
Trials & Approvals
Roche Announces Analysis of Hemlibra’s Phase III HAVEN 2 Study at ASH meeting
2018-12-21
1 … 46 47 48 49 50
LATEST
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top